Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.3K Buy
208
+7
+3% +$2.4K 0.02% 344
2026
Q1
$70.7K Buy
201
+32
+19% +$11.4K 0.02% 302
2025
Q4
$55.3K Hold
169
0.02% 308
2025
Q3
$47.8K Sell
169
-11
-6% -$3.19K 0.01% 322
2025
Q2
$50.4K Buy
180
+14
+8% +$3.97K 0.02% 206
2025
Q1
$51.9K Buy
166
+27
+19% +$7.97K 0.02% 179
2024
Q4
$36.3K Hold
139
0.01% 229
2024
Q3
$44.8K Hold
139
0.02% 158
2024
Q2
$43.4K Buy
139
+2
+1% +$588 0.01% 169
2024
Q1
$39K Sell
137
-2,942
-96% -$861K 0.01% 176
2023
Q4
$887K Sell
3,079
-203
-6% -$55.3K 0.25% 43
2023
Q3
$882K Sell
3,282
-22
-0.7% -$5.49K 0.3% 27
2023
Q2
$734K Sell
3,304
-87
-3% -$20.2K 0.27% 86
2023
Q1
$820K Buy
3,391
+253
+8% +$62.1K 0.34% 54
2022
Q4
$824K Buy
+3,138
New +$841K 0.38% 41

Other funds holding AMGN

True Wealth Design's AMGN Position: Q2 2026 in Review

True Wealth Design increased its Amgen (AMGN) stake by 3.5% in Q2 2026, buying an estimated $2.4K and bringing the position to 208 shares worth $75.3K. The position accounts for 0.02% of the portfolio, ranked #344.

True Wealth Design first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $887K in Q4 2023. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • True Wealth Design held 208 shares of Amgen worth $75.3K as of Q2 2026.
  • True Wealth Design bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.02% of True Wealth Design's portfolio in Q2 2026, its #344 holding.
  • True Wealth Design first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's Amgen position peaked at $887K in Q4 2023.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.